BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37080629)

  • 21. Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland.
    Baysson H; Pennachio F; Wisniak A; Zabella ME; Pullen N; Collombet P; Lorthe E; Joost S; Balavoine JF; Bachmann D; Azman A; Pittet D; Chappuis F; Kherad O; Kaiser L; Guessous I; Stringhini S;
    BMJ Open; 2022 Jan; 12(1):e055515. PubMed ID: 35105645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary long-term consequences of COVID-19 infections after hospital discharge.
    Blanco JR; Cobos-Ceballos MJ; Navarro F; Sanjoaquin I; Arnaiz de Las Revillas F; Bernal E; Buzon-Martin L; Viribay M; Romero L; Espejo-Perez S; Valencia B; Ibañez D; Ferrer-Pargada D; Malia D; Gutierrez-Herrero FG; Olalla J; Jurado-Gamez B; Ugedo J
    Clin Microbiol Infect; 2021 Jun; 27(6):892-896. PubMed ID: 33662544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort.
    González J; Benítez ID; Carmona P; Santisteve S; Monge A; Moncusí-Moix A; Gort-Paniello C; Pinilla L; Carratalá A; Zuil M; Ferrer R; Ceccato A; Fernández L; Motos A; Riera J; Menéndez R; Garcia-Gasulla D; Peñuelas O; Bermejo-Martin JF; Labarca G; Caballero J; Torres G; de Gonzalo-Calvo D; Torres A; Barbé F;
    Chest; 2021 Jul; 160(1):187-198. PubMed ID: 33676998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twelve-month clinical, functional, and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.
    Bongiovanni M; Barilaro G; Bini F
    J Med Virol; 2023 Feb; 95(2):e28524. PubMed ID: 36695513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.
    Wu X; Liu X; Zhou Y; Yu H; Li R; Zhan Q; Ni F; Fang S; Lu Y; Ding X; Liu H; Ewing RM; Jones MG; Hu Y; Nie H; Wang Y
    Lancet Respir Med; 2021 Jul; 9(7):747-754. PubMed ID: 33964245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective evaluation of lung function at three and six months in patients with previous SARS-COV-2 pneumonia.
    Orzes N; Pini L; Levi G; Uccelli S; Cettolo F; Tantucci C
    Respir Med; 2021 Sep; 186():106541. PubMed ID: 34280885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular implications and physical activity in middle-aged and older adults with a history of COVID-19 (CV COVID): a protocol for a randomised controlled trial.
    Rahman M; Russell SL; Okwose NC; Hood OMA; Harwood AE; McGregor G; Raleigh SM; Sandhu H; Roden LC; Maddock H; Banerjee P; Jakovljevic DG
    Trials; 2023 May; 24(1):328. PubMed ID: 37179415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac abnormalities in Long COVID 1-year post-SARS-CoV-2 infection.
    Roca-Fernandez A; Wamil M; Telford A; Carapella V; Borlotti A; Monteiro D; Thomaides-Brears H; Kelly M; Dennis A; Banerjee R; Robson M; Brady M; Lip GYH; Bull S; Heightman M; Ntusi N; Banerjee A
    Open Heart; 2023 Feb; 10(1):. PubMed ID: 36822818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of life and long-term outcomes after hospitalization for COVID-19: Protocol for a prospective cohort study (Coalition VII).
    Rosa RG; Robinson CC; Veiga VC; Cavalcanti AB; Azevedo LCP; Machado FR; Berwanger O; Avezum Á; Lopes RD; Lisboa TC; Teixeira C; Zampieri FG; Tomazini BM; Kawano-Dourado L; Schneider D; Souza D; Santos RDRMD; Silva SSD; Trott G; Gimenes BDP; Souza AP; Barroso BM; Costa LS; Brognoli LG; Pelliccioli MP; Studier NDS; Schardosim RFC; Haubert TA; Pallaoro VEL; Oliveira DM; Velho PI; Medeiros GS; Gazzana MB; Zavascki AP; Pitrez PM; Oliveira RP; Polanczyk CA; Nasi LA; Hammes LS; Falavigna M
    Rev Bras Ter Intensiva; 2021; 33(1):31-37. PubMed ID: 33886851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
    Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
    BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twelve-month follow-up after hospitalization for SARS-COV-2: Physiology improves, symptoms remain.
    Sperling S; Leth S; Fløe A; Hyldgaard C; Gissel T; Topcu A; Kristensen L; Sønderskov Dahl L; Martin Schmid J; Jensen-Fangel S; Bendstrup E
    Infect Dis Now; 2023 Sep; 53(6):104686. PubMed ID: 36842501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations.
    Varisco B; Bai F; De Benedittis S; Tavelli A; Cozzi-Lepri A; Sala M; Miraglia FG; Santoro MM; Ceccherini-Silberstein F; Shimoni Y; Ravid S; Kozlovski T; König F; Pfeifer N; Shamsara E; Parczewski M; Monforte AD; Incardona F; Mommo C; Marchetti G
    BMC Infect Dis; 2023 Oct; 23(1):684. PubMed ID: 37833640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, radiological and functional outcomes in patients with SARS-CoV-2 pneumonia: a prospective observational study.
    Gianella P; Rigamonti E; Marando M; Tamburello A; Grazioli Gauthier L; Argentieri G; Puligheddu C; Pagnamenta A; Pons M; Fusi-Schmidhauser T
    BMC Pulm Med; 2021 Apr; 21(1):136. PubMed ID: 33902513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Term Impact on Lung Function of Patients With Moderate and Severe COVID-19. A Prospective Cohort Study.
    Qureshi S; Nasir N; Rashid N; Ahmed N; Haq Z; Qamar F
    Front Public Health; 2021; 9():663076. PubMed ID: 34950621
    [No Abstract]   [Full Text] [Related]  

  • 40. Repair of Acute Respiratory Distress Syndrome by Stromal Cell Administration in COVID-19 (REALIST-COVID-19): A structured summary of a study protocol for a randomised, controlled trial.
    Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; O'Kane C; McAuley DF
    Trials; 2020 Jun; 21(1):462. PubMed ID: 32493473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.